期刊文献+

多西他赛合奥沙利铂治疗非小细胞肺癌的疗效及安全性评价 被引量:2

下载PDF
导出
摘要 非小细胞肺癌(NSCLC)是肺癌的主要类型,大部分NSCLC患者在发现时已处于晚期,无法接受手术治疗,联合化疗是其主要的治疗手段[1]。顺铂为临床常用的一线化疗药物,但毒副作用明显,降低了患者生存质量[2]。我院对非小细胞肺癌患者改用多西他赛联合奥沙利铂治疗,疗效显著。现报道如下:
作者 吴青
出处 《实用中西医结合临床》 2013年第7期64-65,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献3

二级参考文献23

  • 1臧爱华.2007年ASCO非小细胞肺癌内科治疗进展[J].肿瘤防治研究,2008,35(S1):4-5. 被引量:7
  • 2Jemal A,Murray T,Ward E,et al.Cancer statistics2006[J].CA Cancer J Clin,256,56(2):106-130.
  • 3Kennedy BJ.The snail's pace of lung carcinoma chemotherapy[J].Cancel,1998,82(5):801-803.
  • 4Stewart LA,Pignon JP.Chemotherapy in non-small cell lung Cancel:a meta-analysis using updated data on individual patients from 52 randomised clinical trials[J].BMJ,1995,311:899-909.
  • 5Rinaldi M,Cauchi C,Gridelli C.First line chemotherapy in advanced of metastatic NSCLC[J].Ann Onc,2006,17:64-67.
  • 6Francesco G,Marianna A,Carlotta D,et al.Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer:a meta-analytical approach[J].OncologJst,2009,14:497-510.
  • 7Nizar M,Zhang XD.Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-jun NH2-terminal kinase and inhibited by the mitogenactivated protein kinase extracellular signal-regulated kinase 1/2 pathway[J].Clin Cancer Res,2007,13:1308-1314.
  • 8Hotta K,Matsuo K,Ucoka H,et al.Metaanalysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer[J].J Clin Oncol,2004,22:3852-3859.
  • 9Scheeff ED,Briggs JM,Howell SB.Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin[J].Mol Pharmacol,1999,56:633-643.
  • 10Raymond E,Faive S,Chaney S,et al.Cellular and molecular pharmacology of oxaliplatin[J].Mol Cancer Ther,2002,1:227-235.

共引文献21

同被引文献20

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部